Data / Form D filings / Elastrin Therapeutics, Inc.
Elastrin Therapeutics, Inc.: Form D filings
Elastrin Therapeutics, Inc., a biotechnology company in Greenville, SC, filed 8 Form D notices with the SEC between 2021 and 2025. The latest, on March 11, 2025, reports $500,000 sold of a $500,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200C PATEWOOD DR., Greenville, SC, 29615
- Phone
- (864) 650-7155
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1848350
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 11, 2025 | Amendment | $500,000 | $500,000 | 1 | Sep 11, 2024 | sec.gov | |
| Sep 12, 2024 | New notice | $500,000 | $50,000 | $450,000 | 1 | Sep 11, 2024 | sec.gov |
| Nov 3, 2023 | New notice | $4,750,000 | $4,750,000 | 3 | Oct 25, 2023 | sec.gov | |
| Nov 3, 2023 | Amendment | $2,000,000 | $2,000,000 | 2 | Aug 11, 2023 | sec.gov | |
| Sep 8, 2023 | New notice | $2,000,000 | $1,700,000 | $300,000 | 2 | Aug 11, 2023 | sec.gov |
| Mar 25, 2022 | New notice | $10,000,000 | $3,598,000 | $6,402,000 | 3 | Mar 23, 2022 | sec.gov |
| Mar 25, 2022 | Amendment | $2,500,000 | $2,500,000 | 1 | Feb 17, 2021 | sec.gov | |
| Mar 1, 2021 | New notice | $2,500,000 | $500,000 | $2,000,000 | 1 | Feb 17, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Naren Vyavahare | Executive Officer, Director |
Every Form D from the week of Mar 10, 2025 · All recent filings in South Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Elastrin Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.